AFP
EW icon

Alpha Financial Partners’s Edwards Lifesciences EW Stock Holding History

Alpha Financial Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,504
Closed -$693K – 99
2024
Q3 		$693K Buy
+10,504
New +$763K 0.49% 43

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Alpha Financial Partners's EW Position: Q4 2024 in Review

Alpha Financial Partners sold out of Edwards Lifesciences (EW) in Q4 2024, closing a stake of 10,504 shares — an estimated $693K sold.

Alpha Financial Partners first reported a position in EW in Q3 2024 and held it in 1 quarter. The position peaked at $693K in Q3 2024. 1,228 funds tracked by Wall St. Rank hold EW as of Q4 2024.

  • Alpha Financial Partners reported no remaining Edwards Lifesciences position as of Q4 2024 after selling out during the quarter.
  • Alpha Financial Partners sold 10,504 Edwards Lifesciences shares in Q4 2024, an estimated $693K.
  • Alpha Financial Partners first reported a position in Edwards Lifesciences in Q3 2024 and held it in 1 quarter.
  • Alpha Financial Partners's Edwards Lifesciences position peaked at $693K in Q3 2024.
  • 1,228 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2024.

Based on Alpha Financial Partners's 13F filing for Q4 2024, filed 10 Feb 2025.